Answers are grounded in this paper and cite their sources.
// Bo Liu 1 , Minxiao Yi 1 , Yang Tang 1 , Qingxu Liu 1 , Hong Qiu 1 , Yanmei Zou 1 , Ping Peng 1 , Lu Zhang 1 , Chunping Hu 2 , Xianglin Yuan 1 1 Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei Province, China 2 Department of Statistics, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei Province, China Correspondence to: Xianglin Yuan, email: yxl@medmail.com.cn Keywords: single nucleotide polymorphism, radiation-induced lung injury, lung cancer, MMP-1, radiotherapy Received: April 25, 2016 Accepted: September 14, 2016 Published: September 21, 2016 ABSTRACT Matrix metalloproteinase-1 (MMP-1) has been implicated in several inflammatory and fibrotic diseases. We hypothesized that genetic variations in the MMP1 promoter region are associated with risk of radiation-induced lung injury (RILI). A cohort of 251 lung cancer patients was genotyped for five single nucleotide polymorphisms in the MMP1 promoter region. We found that rs1144393 AG/GG was strongly correlated with an increased occurrence of grade ≥ 2 RILI ( p = 0.002). Additionally, patients with the rs1144393 AG/GG genotypes exhibited higher MMP-1 expression than patients with the AA genotype in lung tissues ( n = 28, p = 0.022) and plasma samples ( n = 40, p = 0.018). Our results indicated that rs1144393 in the MMP1 promoter region can be a predictor of grade ≥ 2 RILI in lung cancer patients treated with thoracic radiation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: